CN105861719A - Primer, probe and kit for evaluating skin anti-aging condition - Google Patents

Primer, probe and kit for evaluating skin anti-aging condition Download PDF

Info

Publication number
CN105861719A
CN105861719A CN201610365084.8A CN201610365084A CN105861719A CN 105861719 A CN105861719 A CN 105861719A CN 201610365084 A CN201610365084 A CN 201610365084A CN 105861719 A CN105861719 A CN 105861719A
Authority
CN
China
Prior art keywords
skin
aging
ability
gene
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610365084.8A
Other languages
Chinese (zh)
Inventor
纪志梁
王毛阳
杨志云
刘晓瑜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujian Aiwo Health Biotechnology Co Ltd
Original Assignee
Fujian Aiwo Health Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujian Aiwo Health Biotechnology Co Ltd filed Critical Fujian Aiwo Health Biotechnology Co Ltd
Priority to CN201610365084.8A priority Critical patent/CN105861719A/en
Publication of CN105861719A publication Critical patent/CN105861719A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Abstract

The invention discloses a primer, a probe and a kit for evaluating the skin anti-aging condition. The sequences of the primer and the probe are shown as SEQ ID NO:1-4, SEQ ID NO:5-8, SEQ ID NO:9-12, SEQ ID NO:13-16, SEQ ID NO:17-20, SEQ ID NO:21-22 and SEQ ID NO:23-24, wherein the ends 5' and the ends 3' of SEQ ID NO:3-4, 7-8, 11-12, 15-16 and 19-20 are connected with different fluorescent marks respectively. The invention further discloses a method for assisting a client in selecting a correct beautifying method through gene detection. Internal causes and external causes generated by skin aging of the client are known, an individual beauty and health solution is provided for the client, and the effect of an anti-aging beautifying product is maximal.

Description

A kind of primer for assessing skin anti-aging situation and probe and test kit
Technical field
The present invention relates to beauty treatment fields, particularly relate to a kind of primer for assessing skin anti-aging situation and probe and test kit.
Background technology
SNP (single nucleotide polymorphism) refers to the variation of single core thuja acid on genome, including conversion, transversion, disappearance and Insert, be a kind of modal genetic marker, in crowd, carry frequency more than 1%, be widely used in diagnosing human disease, The fields such as the use of medicine individuation, Basic of Biology research.Along with different SNP site researchs are goed deep into, by multiple SNP The combine detection in site and follow-up data analysis, can formulate personalized health for the gene information of different crowd and solve Scheme.
The skin appearance of human body is affected by endogenous cause of ill and exopathogenic factor, and exopathogenic factor includes ultraviolet, environmental pollution, improper cosmetics Using, endogenous cause of ill is then embodied in the Biochemical changes relevant to skin, including protein active, hormone level etc., and these changes Mostly determined by gene.Mostly the skin care method of present stage is to take according to exopathogenic factor, as use sunscreen cream, Wetting agent etc., but these have little effect mostly without maintenance method targetedly, cure the symptoms, not the disease.Along with carrying of living standard Height, increasing for improving the demand of skin smooth and tautness, carrying out specific aim beauty and skin care in conjunction with internal and external reasons will be than biography System method more advantage, the most accurately understands endogenous cause of ill and seems most important.
Be there is again multiple SNP site by multiple effect genes, each gene in skin aging process, these sites can affect phase The enzymatic activity of correlation gene.The skin anti-aging ability that can evaluate and test Different Individual is detected, also by the SNP site of related gene Can assess whether relevant anti-aging beauty-care product is applicable to tester, make product effect reach to maximize, tie on this basis Close daily life custom to adjust, make cosmetic result promote further.For this detection method, choose Sites Combination accurately And subsequent data analysis is particularly important.Having patent/patent applications report both at home and abroad utilizes SNP site genotype to judge beauty treatment Product is suitable for skin type, but there are still susceptible SNP site and choose inaccurate, testing result the most energetic total score analysis and ask Topic.Currently have no and combine different genes SNP site combine detection and the report of quantization algorithm assessment skin anti-aging ability.
Chinese utility model patent 201320009798.7 discloses a kind of gene chip, utilize this genechip detection whitening and Aging related gene SNP site, the SNP site of whitening gene include SLC45A2 (re35391), KITLG (rs642742), ASIP (rs1015362), TYR (rs1042602), OCA2 (rs1800414), DCT (rs2031526), MC1R (rs885479), The SNP of aging gene include MMP1 (rs1799750), TIMP1 (rs4898), SIRT6 (rs107251), SOD2 (rs4880), NQO1 (rs1800566), TNFA (rs1800629), EPHX (rs1051740), but the gene chip side that this patent uses Method is cumbersome, it is difficult to be suitable for a large amount of detection.Chinese invention patent application 201180056031.3 screened one group old with skin Change relevant gene (LPL, ADIPOQ, PLN etc.), and according to this group genescreen to a kind of aging resistance new material, this is special Not mentioned gene-correlation SNP site in profit application.Chinese patent application 201080044917.1 provide one utilize natural instead Justice polynucleotide or compound are used for regulating and controlling FLG gene expression, thus reach prevention or treat the disease relevant to FLG.
United States Patent (USP) US200812286033 induces related gene expression to reach to improve the effect of wrinkle by Monoterpenes. United States Patent (USP) US200912512368 induces the expression of ELN and COL3A1 gene by the cosmetics containing iso-amylene isoflavone, Thus reach to improve the effect of skin appearance.United States Patent (USP) US201514618080 and US201313932565 are by skin Old and feeble position uses Carlina acaulis extract and olive oil extract, makes the related gene including ELN and COL3A1 be adjusted Control up-regulated expression, thus reach to improve effect of ageing skin.
Above patent/patent application all utilizes foreign substance to regulate and control the intragentic expression of body, but deposits in the gene of each individuality In difference SNP site, this method is difficult to reach personalized maintenance or treatment.British patent GB20110021917 have detected The target gene SNP site relevant to cosmetics ingredients Biogenic approach, and then judge that whether this product is not suitable for use with person, The SNP site that this patent relates to has MMP-1 (rs1799750), NQO1 (rs1800566), GSTP1 (rs1695), hGPX1 (rs10504)。
Summary of the invention
It is an object of the invention to provide a kind of primer for assessing skin anti-aging situation and probe.
For achieving the above object, the present invention provides a kind of primer for assessing skin anti-aging situation and probe, and its feature exists In, described sequence such as SEQ ID NO:1-4, and SEQ ID NO:5-8, and SEQ ID NO:9-12, and SEQ ID NO:13-16, With SEQ ID NO:17-20, and SEQ ID NO:21-22, and SEQ ID NO:23-24;Wherein SEQ ID 5 ' the ends of NO:3-4,7-8,11-12,15-16,19-20 connect different fluorescent labelinies respectively with 3 ' ends.
The present invention also provides for a kind of test kit for assessing skin anti-aging situation, it is characterised in that containing described primer And probe.
The present invention also provides for a kind of method utilizing the gene test auxiliary correct beauty method of customer selecting, it is characterised in that make With described primer and probe, or gene test is utilized to assist the correct beauty method of customer selecting described in the test kit described in using Method, it is characterised in that step is:
1) use described in primer and probe or described test kit client is carried out SNP site detection;
2) the skin anti-aging ability value of client is gone out according to susceptible SNP site combination calculation;Described susceptible SNP site is combined as SOD2rs4880、SOD2rs5746136、NQO1rs1800566、GPX3rs3828599、GPX1rs1050450、 GSTM1GSTM1-null、GSTT1GSTT1-null;
3) combine 1) SNP site testing result and 2) skin anti-aging ability value, carry out result judgement.
Further, described step 1) be,
Extract the DNA sample of client;
Described primer and probe or described test kit is used to carry out PCR amplification;Preferably, the response procedures of PCR amplification is 50 DEG C 2min, 95 DEG C of 10min, 95 DEG C of 15s, 60 DEG C of 1min circulate 40 times.
Further, described step 2) be,
The pathogenic risk ratio ratio of each loci gene type according to the combination of known susceptible SNP site calculates integrated risk ratio Ratio OR (C), calculation equation is:
Produce average risk ratio odds (D) by known Chinese population different age group skin aging, calculate detection individuality Skin aging produce value-at-risk ratio odds (X), calculating formula is odds (X)=OR (C) × odds (D);
Calculate integrated risk value:
According to known normal genotype crowd's value-at-risk F (N), calculate individual's skin defying age ability value:
Further, described step 3) result be judged as,
1) if individual's skin defying age ability value is less than 100%, then it represents that the skin anti-aging ability of this individuality is less than this age The normal value of Duan Renqun, defying age ability, belong to the oldest and the most feeble body constitution;Ability value is the lowest, and defying age ability is the most weak;
2) if individual's skin defying age ability value is equal to 100%, then it represents that the skin anti-aging ability of this individuality and this age bracket The normal value of crowd is the same, and defying age ability is general;
3) if individual's skin defying age ability value is higher than 100%, then it represents that the skin anti-aging ability of this individuality is higher than this age The normal value of Duan Renqun, defying age ability is preferable, belongs to the body constitution being difficult to aging;Ability value is the highest, and defying age ability is the strongest;
Simultaneously;
If SNP site rs4880 of gene SOD2 is A/G, show to carry heterozygous mutant, activity of SOD Reducing, skin oxidation resistance declines, and easily produces macule, acne etc., and skin becomes obscure tarnish, the most aging; If G/G, showing to carry homozygous mutation, activity of SOD reduces, and skin oxidation resistance declines, and easily produces Raw macule, acne etc., skin becomes obscure tarnish, the most aging;If A/A, then it it is normal genotype;
If SNP site rs5746136 of gene SOD2 is C/T, showing to carry heterozygous mutant, activity of SOD reduces, Skin oxidation resistance declines, easily old and feeble;If T/T, showing to carry homozygous mutation, activity of SOD reduces, skin Oxidation resistance declines, easily old and feeble;If C/C, then it it is normal genotype;
If SNP site rs1800566 of Gene NQO1 is A/A, showing to carry homozygous mutation, skin oxidation resistance declines, Easily producing macule, acne etc., skin becomes obscure tarnish, the most aging;If A/G, show to carry heterozygous mutant, skin Oxidation resistance declines, and easily produces macule, acne etc., and skin becomes obscure tarnish, the most aging;If G/G, then just it is Often genotype;
If SNP site rs3828599 of gene GPX3 is A/G, showing to carry heterozygous mutant, on accelerating, skin aging impact is little; If G/G, showing to carry homozygous mutation, enzymatic activity reduces, and skin toxin expelling ability reduces, and is easily subject to external environment and free radical Destroy, accelerate skin aging;If A/A, then it it is normal genotype;
If SNP site rs1050450 of gene GPX1 is A/A, showing to carry homozygous mutation, enzymatic activity reduces, skin toxin expelling energy Power reduces, and is easily subject to the destruction of external environment and free radical, accelerates skin aging;If A/G, show to carry homozygous mutation, enzyme Activity reduces, and skin toxin expelling ability reduces, and is easily subject to the destruction of external environment and free radical, accelerates skin aging;If G/G, then For normal genotype;
If gene GSTM1 is GSTM1-null, showing gene delection, internal lack this enzyme, total antioxidant status weakens, health toxin expelling Ability is poor, the most aging;If GSTM1-present, then it it is normal genotype;
If gene GSTT1 is GSTT1-null, showing gene delection, internal lack this enzyme, total antioxidant status weakens, health toxin expelling Ability is poor, the most aging;If GSTT1-present, then it it is normal genotype.
The present invention (1) filters out one group and can verify through too much piece document, and molecular mechanism is clear, can be used for comprehensive accurate evaluation The SNP site combination of skin anti-aging ability;(2) high specificity, highly sensitive TaqMan-MGB probe in detecting side are used Method detects, and can detect multiple sample simultaneously;(3) anti-ageing with assessment skin by algorithm precise quantification skin aging risk Old ability, provides personalized skin anti-aging scheme for tester.
The technical solution used in the present invention is: binding molecule Mechanism Study, literature search and clinical data screening, obtains one group The susceptible SNP site combination that skin aging is relevant, described combination site is respectively SOD2 (rs4880, rs5746136), NQO1 (rs1800566)、GPX3(rs3828599)、GPX1(rs1050450)、GSTM1(GSTM1-null)、GSTT1 (GSTT1-null), the site information of described combination is shown in Table 1, and this combination site can resist with the skin of accurate evaluation Different Individual Old and feeble ability.
Table 1 susceptible SNP site information table
In order to detect described site, applicant devises the primer needed for detection and probe, and described primer and fluorescent probe are as follows (underscore is SNP site):
SOD2 (rs4880) primer and fluorescent probe sequence:
SOD2 (rs5746136) primer and fluorescent probe sequence:
NQO1 (rs1800566) primer and fluorescent probe sequence:
GPX3 (rs3828599) primer and fluorescent probe sequence:
GPX1 (rs1050450) primer and fluorescent probe sequence:
GSTM1 (GSTM1-null) primer sequence:
Forward primer GAACTCCCTGAAAAGCTAAAGC SEQ ID NO:21
Reverse primer GTTGGGCTCAAATATACGGTGG SEQ ID NO:22
GSTT1 (GSTT1-null) primer sequence:
Forward primer TTCCTTACTGGTCCTCACATCTC SEQ ID NO:23
Reverse primer TCACCGGATCATGGCCAGCA SEQ ID NO:24;
Described loci detection method specifically comprises the following steps that
Described loci detection method specifically comprises the following steps that
1, human saliva sample collection.Using non-injurious salivary automatically to flow out acquisition mode, before saliva gathers, 30min need to be with drink With foreign material in water cleaning oral cavity, gather 2mL saliva and deposit in saliva preservation liquid for detection.
2, human body complete genome DNA extracts.Use potassium iodide method, with reference to concretely comprising the following steps: take 0.1mL saliva in 1.5mL In centrifuge tube, adding 500 μ L 0.01mol/L PBS solution and repeatedly blow and beat, 10000rpm is centrifuged 5min;Remove supernatant, Precipitation adds 50 μ L5mol/L KI solution, concussion mixing, adds 100 μ L 0.9%NaCl solution, 150 μ L phenol / chloroform (25: 24, V/V) mixed liquor, concussion 30s, 10000rpm are centrifuged 5min;Take 200 μ L of supernatant, add 200 μ L Isopropanol, mixing, 10000rpm is centrifuged 5min;Removing supernatant, precipitation adds 1mL absolute ethanol washing, 10000rpm from Heart 5min;Abandoning dehydrated alcohol, be deposited in super-clean bench and dry up, add 50 μ L TE buffer solution ,-20 DEG C save backup.
3, PCR reaction system and response procedures.10 μ L reaction systems containUniversal PCR Master Mix (Applied Biosystems, Applied Biotechnology company limited of the U.S.) 5 μ L, DNA profiling 1 μ L, fluorescent probe are (every The detection correspondence probe of individual SNP site mixes) (detection of each SNP site is right for (2.5 μMs) and primer mixed liquor Primer is answered to mix) 1.5 μ L, ddH2O 2.5μL.Response procedures is 50 DEG C of 2min, 95 DEG C of 10min, 95 DEG C of 15s, 60 DEG C of 1min circulate 40 times.Detecting instrument be StepOnePlus real-time fluorescence quantitative PCR instrument (Applied Biosystems, Applied Biotechnology company limited of the U.S.).
4, interpretation.Use StepOnePlusTM(Applied Biosystems, the U.S. should for Software v2.3 With Bioisystech Co., Ltd) it is analyzed, according to different fluorescence signals, draw the genotype of corresponding SNP site.
Skin anti-aging ability quantization method is as follows:
1, skin aging integrated risk ratio is than calculating.The risk ratio of each loci gene type of known detection gained is than respectively For OR1、OR2…ORm(literature query is learnt, the results are shown in Table 3), can calculate Individual senescence integrated risk ratio and compare OR (C), calculation equation is as follows:
O R ( C ) = Π k = 1 n OR m .
2, the Individual senescence integrated risk ratio calculated by step 1 is than OR (C), by document or other statistical approach Chinese population different age group skin aging average risk ratio odds (D) (known Chinese population different age group can be obtained Skin aging produce average risk ratio odds (D) be respectively as follows: 20-35 year: 0.09,36-45 years old: 0.21,46-55 Year: 0.48), can calculate, by odds ratio computing formula, skin aging value-at-risk ratio odds (X) that detection is individual, Calculation equation is as follows:
O R ( C ) = o d d s ( X ) o d d s ( D ) .
3, the individual's skin aging calculated by step 2 produces risk ratio odds (X), i.e. can be pushed away by value-at-risk Calculating formula and can calculate integrated risk value F (X), calculation equation is as follows:
F ( X ) = o d d s ( X ) o d d s ( X ) + 1 .
4, the skin anti-aging ability of Different Individual can be assessed by the calculated integrated risk value of step 3, it is known that normal Genotype crowd's value-at-risk F (N) (known normal genotype crowd's value-at-risk F (N) is 8.26% to be respectively as follows: 20-35 year: 8.26%, 36-45 year: 17.35%, 46-55 year: 32.43%), individual's skin defying age ability value V can be calculated, meter Calculation equation is as follows:
V = F ( N ) F ( X ) × 100 % .
Testing result personality analysis and solution:
According to defying age ability quantum chemical method result, in conjunction with function and the molecular mechanism of related locus, it is judged that skin problem can Energy property, assessment tester can use the cosmetics containing which kind of composition, and adjust the daily life being conducive to skin protection for it Dietary habit.The molecular mechanism of related gene is as follows: if SOD2 carries sudden change, can accelerate skin aging;NQO1 carries Sudden change, skin oxidation resistance declines, easily old and feeble;GPX3 and GPX1 carries sudden change, and skin oxidation resistance declines, Skin easy damaged;GSTM1 and GSTT1 carries sudden change, and noxious substance easily accumulates at skin, toxin expelling ability, easily old and feeble.
Beneficial effect:
Endogenous cause of ill and the exopathogenic factor of skin aging can be fully understood by, provide the user personalized beauty care health solution, make anti-ageing Old cosmetics using effect maximizes.Further, it is also possible to adjust the daily life dietary habit being conducive to skin protection for tester.
Detailed description of the invention
Embodiments of the invention are described below in detail, and the example of described embodiment is being intended to for explaining the present invention, and can not manage Solve as limitation of the present invention.Unreceipted concrete technology or condition person in embodiment, described by the document in this area Technology or condition or carry out according to product description.Agents useful for same or instrument unreceipted production firm person, be and can pass through City available from conventional products.
Embodiment 1: primer and probe design
1, design and synthesize following primer and probe, synthesize unit: Applied Biosystems, U.S.'s Applied Biotechnology is limited Company.
SOD2 (rs4880) primer and fluorescent probe sequence:
SOD2 (rs5746136) primer and fluorescent probe sequence:
NQO1 (rs1800566) primer and fluorescent probe sequence:
GPX3 (rs3828599) primer and fluorescent probe sequence:
GPX1 (rs1050450) primer and fluorescent probe sequence:
GSTM1 (GSTM1-null) primer sequence:
Forward primer GAACTCCCTGAAAAGCTAAAGC SEQ ID NO:21
Reverse primer GTTGGGCTCAAATATACGGTGG SEQ ID NO:22
GSTT1 (GSTT1-null) primer sequence:
Forward primer TTCCTTACTGGTCCTCACATCTC SEQ ID NO:23
Reverse primer TCACCGGATCATGGCCAGCA SEQ ID NO:24
2, SNP site detection
1), sample collection.Detection sample in the present embodiment uses human saliva, and before saliva gathers, 30min need to be with drinking Foreign material in water cleaning oral cavity, gather 2mL saliva and deposit in saliva preservation liquid (purchased from the kind limited public affairs of biotechnology share of Xiamen cause Department) for detection.
2), human body complete genome DNA extracts.Use potassium iodide method, with reference to concretely comprising the following steps: take 0.1mL saliva in 1.5 In mL centrifuge tube, adding 500 μ L 0.01mol/L PBS solution and repeatedly blow and beat, 10000rpm is centrifuged 5min;Remove supernatant, Precipitation adds 50 μ L5mol/L KI solution, concussion mixing, adds 100 μ L 0.9%NaCl solution, 150 μ L phenol / chloroform (25: 24, V/V) mixed liquor, concussion 30s, 10000rpm are centrifuged 5min;Take 200 μ L of supernatant, add 200 μ L Isopropanol, mixing, 10000rpm is centrifuged 5min;Removing supernatant, precipitation adds 1mL absolute ethanol washing, 10000rpm from Heart 5min;Abandoning dehydrated alcohol, be deposited in super-clean bench and dry up, add 50 μ L TE buffer solution ,-20 DEG C save backup.
3), reaction system and response procedures 10 μ L reaction system containUniversal PCR Master Mix (Applied Biosystems, Applied Biotechnology company limited of the U.S.) 5 μ L, DNA profiling 1 μ L, fluorescent probe are (every The detection correspondence probe of individual SNP site mixes) (detection of each SNP site is right for (2.5 μMs) and primer mixed liquor Primer is answered to mix) 1.5 μ L, ddH2O 2.5μL.Response procedures is 50 DEG C of 2min, 95 DEG C of 10min, 95 DEG C of 15s, 60 DEG C of 1min circulate 40 times.Detecting instrument be StepOnePlus real-time fluorescence quantitative PCR instrument (Applied Biosystems, Applied Biotechnology company limited of the U.S.).
4), detection program end of run after, use StepOnePlusTMSoftware v2.3 (Applied Biosystems, Applied Biotechnology company limited of the U.S.) testing result is analyzed, draw the genotype (being shown in Table 2) of corresponding SNP.
Table 2 SNP site testing result table
3, defying age ability quantitative evaluation and personalized solution
1), skin aging integrated risk value calculates.Learnt by literature query, the old and feeble risk ratio such as table of different loci Shown in 3.
Risk ratio ratio (OR) table of table 3 related locus genotype
(1) Individual senescence integrated risk ratio is than calculating.The OR value of different loci is as shown in table 3, then
(2) calculate Individual senescence integrated risk ratio by step (1) to obtain than OR (C), comprehensive literature and survey data Know that the ratio odds (D) of Chinese population 20-35 age bracket skin aging is about that 0.09 (the detection sample of the present embodiment belongs to This age bracket, therefore select the data of this age bracket), can calculate, by odds ratio computing formula, the skin aging that detection is individual Value-at-risk ratio odds (X)=OR (C) × odds (D)=2.25 × 0.09=0.20.
(3) detection Individual senescence risk ratio odds (X) calculated by step (2), integrated risk value
(4) known normal genotype crowd's allergy value-at-risk F (N) is 8.26%, can calculate resisting skin allergy ability value
2), testing result is comprehensively analyzed.This individual's skin defying age ability value is 49.55%, and skin anti-aging ability is poor, The oldest and the most feeble.In combination with the molecular mechanism of related gene, the GPX3 in this detection individuality carries susceptibility loci as shown in Table 2 Homozygous mutation, NQO1 carries susceptibility loci heterozygous mutant, and these sudden changes can affect glutathion peroxidase 3 and quinone oxidation Reductase 1 activity, affects skin oxidation resistance, skin easy damaged, thus causes aging.
3), personalized solution: this individuality belongs to skin easily old and feeble skin quality, and the sudden change of GPX3, NQO1 gene makes body The oxidation resistance of heredity is more weak, easily old and feeble.Daily life should be noted the selection of cosmetics, should select containing tocopheryl acetate The cosmetic product that the antioxidant compositions such as ester, grape polyphenols, co-ferment Q10 are high.Reduce contact ultraviolet, X-ray, wine Essence, some medicine and pollutant etc. may result in the factor that free radical produces;How edible containing three big antioxidant (vitamin E, vitamin C, beta-carotene) food, such as Garcinia mangostana, Radix Dauci Sativae, Punica granatum L. etc.;Reduce erratic living habit etc. The factor impact on skin.
Although above it has been shown and described that embodiments of the invention, it is to be understood that above-described embodiment is exemplary, Being not considered as limiting the invention, those of ordinary skill in the art is without departing from the principle of the present invention and the situation of objective Under above-described embodiment can be changed within the scope of the invention, revise, replace and modification.

Claims (7)

1. primer and the probe being used for assessing skin anti-aging situation, it is characterised in that described sequence such as SEQ ID NO:1-4, and SEQ ID NO:5-8, and SEQ ID NO:9-12, and SEQ ID NO:13-16, and SEQ ID NO:17-20, With SEQ ID NO:21-22, and SEQ ID NO:23-24;Wherein SEQ ID NO:3-4,7-8,11-12,15-16,19-20 5 ' end and 3 ' end respectively connection different fluorescent labelinies.
2. the test kit being used for assessing skin anti-aging situation, it is characterised in that containing the primer described in claim 1 And probe.
3. the method utilizing the gene test auxiliary correct beauty method of customer selecting, it is characterised in that use claim The primer of 1 and probe, or use the test kit of claim 2.
4. the method utilizing the gene test auxiliary correct beauty method of customer selecting described in claim 3, it is characterised in that step Suddenly it is:
1) use the primer of claim 1 and the test kit of probe or claim 2 that client is carried out SNP site detection;
2) the skin anti-aging ability value of client is gone out according to susceptible SNP site combination calculation;Described susceptible SNP site is combined as SOD2rs4880、SOD2rs5746136、NQO1rs1800566、GPX3rs3828599、GPX1rs1050450、 GSTM1GSTM1-null、GSTT1GSTT1-null;
3) combine 1) SNP site testing result and 2) skin anti-aging ability value, carry out result judgement.
5. the method utilizing the gene test auxiliary correct beauty method of customer selecting described in claim 4, it is characterised in that institute State step 1) be,
Extract the DNA sample of client;
Test kit described in primer described in claim 1 and probe or claim 2 is used to carry out PCR amplification;Preferably, PCR The response procedures of amplification is 50 DEG C of 2min, 95 DEG C of 10min, and 95 DEG C of 15s, 60 DEG C of 1min circulate 40 times.
6. the method utilizing the gene test auxiliary correct beauty method of customer selecting described in claim 4, it is characterised in that institute State step 2) be,
The pathogenic risk ratio ratio of each loci gene type according to the combination of known susceptible SNP site calculates integrated risk ratio Ratio OR (C), calculation equation is:
Produce average risk ratio odds (D) by known Chinese population different age group skin aging, calculate detection individuality Skin aging produce value-at-risk ratio odds (X), calculating formula is odds (X)=OR (C) × odds (D);
Calculate integrated risk value:
According to known normal genotype crowd's value-at-risk F (N), calculate individual's skin defying age ability value;
7. the method utilizing the gene test auxiliary correct beauty method of customer selecting described in claim 4, it is characterised in that institute State step 3) result be judged as,
1) if individual's skin defying age ability value is less than 100%, then it represents that the skin anti-aging ability of this individuality is less than this age The normal value of Duan Renqun, defying age ability, belong to the oldest and the most feeble body constitution;Ability value is the lowest, and defying age ability is the most weak;
2) if individual's skin defying age ability value is equal to 100%, then it represents that the skin anti-aging ability of this individuality and this age bracket The normal value of crowd is the same, and defying age ability is general;
3) if individual's skin defying age ability value is higher than 100%, then it represents that the skin anti-aging ability of this individuality is higher than this age The normal value of Duan Renqun, defying age ability is preferable, belongs to the body constitution being difficult to aging;Ability value is the highest, and defying age ability is the strongest;
Simultaneously;
If SNP site rs4880 of gene SOD2 is A/G, show to carry heterozygous mutant, activity of SOD Reducing, skin oxidation resistance declines, and easily produces macule, acne etc., and skin becomes obscure tarnish, the most aging; If G/G, showing to carry homozygous mutation, activity of SOD reduces, and skin oxidation resistance declines, and easily produces Raw macule, acne etc., skin becomes obscure tarnish, the most aging;If A/A, then it it is normal genotype;
If SNP site rs5746136 of gene SOD2 is C/T, showing to carry heterozygous mutant, activity of SOD reduces, Skin oxidation resistance declines, easily old and feeble;If T/T, showing to carry homozygous mutation, activity of SOD reduces, skin Oxidation resistance declines, easily old and feeble;If C/C, then it it is normal genotype;
If SNP site rs1800566 of Gene NQO1 is A/A, showing to carry homozygous mutation, skin oxidation resistance declines, Easily producing macule, acne etc., skin becomes obscure tarnish, the most aging;If A/G, show to carry heterozygous mutant, skin Oxidation resistance declines, and easily produces macule, acne etc., and skin becomes obscure tarnish, the most aging;If G/G, then just it is Often genotype;
If SNP site rs3828599 of gene GPX3 is A/G, showing to carry heterozygous mutant, on accelerating, skin aging impact is little; If G/G, showing to carry homozygous mutation, enzymatic activity reduces, and skin toxin expelling ability reduces, and is easily subject to external environment and free radical Destroy, accelerate skin aging;If A/A, then it it is normal genotype;
If SNP site rs1050450 of gene GPX1 is A/A, showing to carry homozygous mutation, enzymatic activity reduces, skin toxin expelling energy Power reduces, and is easily subject to the destruction of external environment and free radical, accelerates skin aging;If A/G, show to carry homozygous mutation, enzyme Activity reduces, and skin toxin expelling ability reduces, and is easily subject to the destruction of external environment and free radical, accelerates skin aging;If G/G, then For normal genotype;
If gene GSTM1 is GSTM1-null, showing gene delection, internal lack this enzyme, total antioxidant status weakens, health toxin expelling Ability is poor, the most aging;If GSTM1-present, then it it is normal genotype;
If gene GSTT1 is GSTT1-null, showing gene delection, internal lack this enzyme, total antioxidant status weakens, health toxin expelling Ability is poor, the most aging;If GSTT1-present, then it it is normal genotype.
CN201610365084.8A 2016-05-27 2016-05-27 Primer, probe and kit for evaluating skin anti-aging condition Pending CN105861719A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610365084.8A CN105861719A (en) 2016-05-27 2016-05-27 Primer, probe and kit for evaluating skin anti-aging condition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610365084.8A CN105861719A (en) 2016-05-27 2016-05-27 Primer, probe and kit for evaluating skin anti-aging condition

Publications (1)

Publication Number Publication Date
CN105861719A true CN105861719A (en) 2016-08-17

Family

ID=56642468

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610365084.8A Pending CN105861719A (en) 2016-05-27 2016-05-27 Primer, probe and kit for evaluating skin anti-aging condition

Country Status (1)

Country Link
CN (1) CN105861719A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106148545A (en) * 2016-08-29 2016-11-23 广州肌因港生物科技有限公司 One group of Primer composition for skin-related gene detection and detection method
CN106755390A (en) * 2016-12-15 2017-05-31 上海东方杰玛基因生物科技有限公司 A kind of Primer composition and detection method for skin anti-aging ability genetic test
CN108251521A (en) * 2018-03-15 2018-07-06 北京天平永达科技发展有限公司 For detecting the primer set of tumor susceptibility gene SNP related to skin aging and its application
CN108950013A (en) * 2018-07-27 2018-12-07 江颖纯 A kind of skin-related gene site library and its construction method and application
CN109207604A (en) * 2018-09-10 2019-01-15 广州益养生物科技有限公司 A kind of method of quick detection heredity skin antioxidant genes
CN110819723A (en) * 2019-11-27 2020-02-21 嘉文丽(福建)化妆品有限公司 Detection method for five gene combinations for assessing congenital skin quality and personalized skin care kit formulated according to detection results
CN111455035A (en) * 2020-01-22 2020-07-28 广州市普森生物科技有限公司 Primer combination and kit for detecting skin anti-aging capability gene and application of primer combination and kit
CN112725437A (en) * 2021-02-02 2021-04-30 暨南大学 Application of rhythm gene protein expression and RNA methylation modification in preparation of aging detection kit
CN112980963A (en) * 2019-12-13 2021-06-18 宁波海尔施基因科技有限公司 Kit for detecting individual skin genes and use method thereof
WO2021235551A1 (en) * 2020-05-22 2021-11-25 株式会社 資生堂 Method for determining resistance against skin aging using genetic polymorphism
CN114686578A (en) * 2020-12-30 2022-07-01 北京本真工坊生物科技有限公司 Skin type assessment method, application and system

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014176425A1 (en) * 2013-04-24 2014-10-30 Skinshift Methods of skin analysis and use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014176425A1 (en) * 2013-04-24 2014-10-30 Skinshift Methods of skin analysis and use thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ARSENIY E. YUZHALIN AND ANTON G. KUTIKHIN: "Inherited variations in the SOD and GPX gene families and cancer risk.", 《FREE RADICAL RESEARCH》 *
GUIXIANG JI ET AL.: "Genetic variants in antioxidant genes are associated with sperm DNA damage and risk of male infertility in a Chinese population.", 《FREE RADICAL BIOLOGY & MEDICINE》 *
JORDI NAVAL ET AL.: "Genetic polymorphisms and skin aging:the identification of polulation genotypic groups holds potential for personalized treatments.", 《CLINICAL, COSMETIC AND INVESTIGATIONAL DERMATOLOGY》 *
MCCARTY ET AL.: "Arsenic Methylation, GSTT1, GSTM1, GSTP1 Polymorphisms, and Skin Lesions.", 《ENVIRONMENTAL HEALTH PERSPECTIVES》 *
付全航 等: "谷胱苷肽S 转硫酶T1、M1和P1基因多态性与结直肠癌易感性的关系", 《实用癌症杂志》 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106148545A (en) * 2016-08-29 2016-11-23 广州肌因港生物科技有限公司 One group of Primer composition for skin-related gene detection and detection method
CN106755390A (en) * 2016-12-15 2017-05-31 上海东方杰玛基因生物科技有限公司 A kind of Primer composition and detection method for skin anti-aging ability genetic test
CN106755390B (en) * 2016-12-15 2020-12-04 上海东方杰玛基因生物科技有限公司 Primer composition for detecting skin anti-aging capability gene and detection method
CN108251521A (en) * 2018-03-15 2018-07-06 北京天平永达科技发展有限公司 For detecting the primer set of tumor susceptibility gene SNP related to skin aging and its application
CN108251521B (en) * 2018-03-15 2021-08-13 北京天平永达科技发展有限公司 Complete set of primers for detecting susceptibility gene SNP related to skin aging and application thereof
CN108950013A (en) * 2018-07-27 2018-12-07 江颖纯 A kind of skin-related gene site library and its construction method and application
CN109207604A (en) * 2018-09-10 2019-01-15 广州益养生物科技有限公司 A kind of method of quick detection heredity skin antioxidant genes
CN110819723A (en) * 2019-11-27 2020-02-21 嘉文丽(福建)化妆品有限公司 Detection method for five gene combinations for assessing congenital skin quality and personalized skin care kit formulated according to detection results
CN112980963A (en) * 2019-12-13 2021-06-18 宁波海尔施基因科技有限公司 Kit for detecting individual skin genes and use method thereof
CN111455035A (en) * 2020-01-22 2020-07-28 广州市普森生物科技有限公司 Primer combination and kit for detecting skin anti-aging capability gene and application of primer combination and kit
WO2021235551A1 (en) * 2020-05-22 2021-11-25 株式会社 資生堂 Method for determining resistance against skin aging using genetic polymorphism
CN114686578A (en) * 2020-12-30 2022-07-01 北京本真工坊生物科技有限公司 Skin type assessment method, application and system
CN112725437A (en) * 2021-02-02 2021-04-30 暨南大学 Application of rhythm gene protein expression and RNA methylation modification in preparation of aging detection kit
CN112725437B (en) * 2021-02-02 2022-12-06 暨南大学 Application of rhythm gene protein expression and RNA methylation modification in preparation of aging detection kit

Similar Documents

Publication Publication Date Title
CN105861719A (en) Primer, probe and kit for evaluating skin anti-aging condition
CN105886646A (en) Primer, probe and kit for evaluating sun protection condition of skin
CN105886645A (en) Primer, probe and kit for evaluating anti-wrinkle condition of skin
Pang et al. Human skin mitochondrial DNA deletions associated with light exposure
JP5905121B2 (en) Product selection using genetic analysis
CN105950738A (en) Primer, probe and kit for evaluating skin anti-allergy condition
US8906425B2 (en) Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers
EP2889384B1 (en) Method for identifying active agents for improving the aesthetic appearance of human skin
CN105803105A (en) Primer, probe and kit for evaluating skin regeneration conditions
EP2225562B1 (en) Oral care methods and systems
Ahmetov et al. The use of molecular genetic methods for prognosis of aerobic and anaerobic performance in athletes
Müller-Oerlinghausen et al. Serotonergic platelet markers of suicidal behavior—do they really exist?
JP2013226096A (en) Method of determining subject's skin quality and method of providing cosmetics based on the same
CN109234385A (en) Detect the primer sets and kit of Alzheimer's disease gene mutation
CN105950737A (en) Primer, probe and kit for evaluating skin defense condition
CN102876791A (en) Gene chip for evaluating risks of suffering from anorectal diseases and preparation method and kit thereof
EP2063858B1 (en) Use of high molecular polysaccharides for their immediate strengthening effect
Costa et al. Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes
Araujo et al. In-mouth attributes driving perceived quality of Pinot noir wines: Sensory and chemical characterisation
Ritsner et al. An association of CAG repeats at the KCNN3 locus with symptom dimensions of schizophrenia
CN105803106A (en) Primer, probe and kit for evaluating skin moisturizing conditions
Iglesia et al. A multi‐functional anti‐aging moisturizer maintains a diverse and balanced facial skin microbiome
Fritschi et al. Risk factors for surgically treated benign prostatic hyperplasia in Western Australia
Gambino et al. Impact of oenological processing aids and additives on the genetic traceability of ‘Nebbiolo’wine produced with withered grapes
GB2438999A (en) Screening for substances that promote the activity or formation of LOXL

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160817